3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Fallopian Tube Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Interventions
mirvetuximab soravtansine
2
Paclitaxel
2
sacituzumab govitecan
1
pembrolizumab
1
liposomal doxorubicin
1
Topotecan
1
Saline Solution
1
Glucose
1
Docetaxel
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Carcinoma, Ovarian Epithelial
×
Topotecan
×
Clear all
NCT04209855
2025-08-27
MIRASOL
AbbVie
Phase 3
Completed
453 enrolled
18 charts
1 FDA